XBiotech Inc. (XBIT): Price and Financial Metrics

XBIT POWR Grades

• Value is the dimension where XBIT ranks best; there it ranks ahead of 93.39% of US stocks.
• The strongest trend for XBIT is in Value, which has been heading up over the past 179 days.
• XBIT's current lowest rank is in the Momentum metric (where it is better than 4.64% of US stocks).

XBIT Stock Summary

• For XBIT, its debt to operating expenses ratio is greater than that reported by merely 0.5% of US equities we're observing.
• XBIT's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 5.55% of US stocks.
• As for revenue growth, note that XBIT's revenue has grown -58.19% over the past 12 months; that beats the revenue growth of only 2.6% of US companies in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to XBiotech Inc are BPMC, KLDO, APTX, IDYA, and CALA.
• Visit XBIT's SEC page to see the company's official filings. To visit the company's web site, go to www.xbiotech.com.

XBIT Valuation Summary

• XBIT's price/sales ratio is 19.3; this is 70.04% higher than that of the median Healthcare stock.
• XBIT's price/sales ratio has moved NA NA over the prior 78 months.
• Over the past 78 months, XBIT's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for XBIT.

XBIT Growth Metrics

Its 3 year cash and equivalents growth rate is now at -84.64%.
• The 2 year cash and equivalents growth rate now stands at 750.01%.
• Its 2 year net cashflow from operations growth rate is now at -193.92%.

Over the past 34 months, XBIT's revenue has gone up $18,394,000.

The table below shows XBIT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	18.394	69.445	-17.414
2021-09-30	19.163	70.813	-12.785
2021-06-30	25.193	81.698	-12.05
2021-03-31	36.166	-2.667	-13.776
2020-12-31	43.997	-65.149	-11.221
2020-09-30	38.728	-68.504	677.111

XBIT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• XBIT has a Quality Grade of D, ranking ahead of 11.91% of graded US stocks.
• XBIT's asset turnover comes in at 0.071 -- ranking 289th of 682 Pharmaceutical Products stocks.
• QLGN, GTHX, and CPHI are the stocks whose asset turnover ratios are most correlated with XBIT.

The table below shows XBIT's key quality metrics over time.